Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bioqual, Inc (BIOQ) Fair Value & Analysis

Healthcare · US · Market cap $29.1M

Price$32.50
Fair Value$40.80
Upside+25.5%
Quality95/100
Evidence: Medium Range $29.00 – $52.60

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Bioqual, Inc (BIOQ) currently trades at $32.50, while our model-based Fair Value estimate is $40.80 — implying the stock looks roughly 25.5% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and tailored assay development services; and Biocontainment, imaging services, and animal model development; and IND-enabling services, such as toxicology studies, pharmacokinetic profiling, GLP services, and regulatory documentation services. Bioqual, Inc. was incorporated in 1981 and is based in Rockville, Maryland.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -56% Danaher Corporation (DHR) -37% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -53% Lonza Group (LZAGY) -74% Agilent Technologies, Inc (A) -50%

Frequently asked questions

Is Bioqual, Inc (BIOQ) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $40.80 versus a price of $32.50 — about +26% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BIOQ?
Our 21-model fair value for Bioqual, Inc is $40.80 (as of Jun 24, 2026), built from audited fundamentals. The current price is $32.50.
What is the quality score of BIOQ?
Bioqual, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.